POLYMEDNSEPoly Medicure Limited· PharmaceuticalsLowNeutral
Announced Mon, 4 Aug · 16:31 IST

Poly Medicure Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Poly Medicure Limited has informed the stock exchanges about an earnings conference call scheduled for Friday, August 8, 2025 at 4:00 PM IST. The call will discuss the company's Unaudited Financial Results for the first quarter ended June 30, 2025 (Q1FY26). The management team will be represented by Managing Director Himanshu Baid, CFO Naresh Vijayvergiya, and President of Strategy & Corporate Development Rahul Gautam. The call is being coordinated by ICICI Securities, with a Diamond Pass registration link shared for investors and analysts to join. The filing has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

This is a routine regulatory disclosure ahead of the Q1FY26 results announcement and does not directly affect the stock price. However, the upcoming earnings call will be a key event for investors as management commentary on margins, revenue growth, and guidance will shape near-term sentiment in the stock.